Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02093130 · ClinicalTrials.gov registry record · Phase 2
Study of Pomegranate Juice on Memory in Older Adults
A Phase 2 study of Impact of Pomegranate Juice on Memory in Older Adults, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 212
- Enrollment target
- 1
- Study location
NCT02093130 is a Phase 2 study of Impact of Pomegranate Juice on Memory in Older Adults that has completed, run by University of California, Los Angeles. The registered enrollment target is 212 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02093130, a Phase 2 study of Impact of Pomegranate Juice on Memory in Older Adults, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 212 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is designed to study whether pomegranate juice benefits cognitive abilities in middle-aged and older non-demented volunteers. Subjects will be randomly assigned to one of two treatment groups: either a placebo or the pomegranate juice. Subjects will drink eight ounces of the pomegranate juice or placebo daily for twelve months. The investigators expect the people receiving the pomegranate juice to show better cognitive performance compared with those receiving a placebo after one, six, and twelve months. The investigators believe cognitive decline and treatment response will vary according to a genetic risk for Alzheimer's. The investigators will study 212 non-demented subjects aged 50-75 years. Initially, subjects will undergo a clinical assessment, an MRI and a blood draw to determine genetic risk and to rule out other neurodegenerative disorders linked to memory complaints. Subsequently, subjects will undergo the first memory (or neuropsychological) assessments. Following the first assessment, subjects will begin drinking the juice (either the pomegranate juice or the placebo). Subjects will undergo a brief memory test at one-month mark. At six months, subjects will have a second, full neuropsychological assessment. The final assessment will take place at the end of the study, the 12-month mark. Additional blood will be drawn at baseline and at 12 months and frozen to assess inflammatory markers if outcomes are positive. In total, subjects will be expected to come to the University of California, Los Angeles (UCLA) for 5 visits during the course of 12-13 months.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Pomegranate Juice
Study Locations (1)
California
- UCLA Longevity Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2014-01 |
| Est. Completion | 2018-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02093130
The ClinicalTrials.gov registry entry for NCT02093130 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Impact of Pomegranate Juice on Memory in Older Adults appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02093130 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02093130 about?
NCT02093130 is a clinical study titled "Study of Pomegranate Juice on Memory in Older Adults". This project is designed to study whether pomegranate juice benefits cognitive abilities in middle-aged and older non-demented volunteers. Subjects will be randomly assigned to one of two treatment groups: either a placebo or the pomegranate juice. Subjects will drink eight ounces of the pomegranate...
What is the current status of trial NCT02093130?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 212 participants. The study started on 2014-01. Estimated completion is 2018-05.
What conditions does trial NCT02093130 study?
This clinical trial studies the following conditions: Impact of Pomegranate Juice on Memory in Older Adults.
What interventions are being tested in trial NCT02093130?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Pomegranate Juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02093130?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02093130 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.